Search the Newsroom
Filter By
News Type
Related specialties and programs
Showing 1 - 4 of 4 results
Children’s Hospital of Philadelphia Researchers Find Hemophilia A Drug May Be Effective for Select People with Hemophilia B
Researchers at Children’s Hospital of Philadelphia (CHOP) found that emicizumab, a widely used drug for hemophilia A, could also improve blood clotting for select people with hemophilia B depending on their genes. The preclinical study, recently published in Blood, offers proof that this class of hemophilia A drug could potentially be used to treat hemophilia B.

CHOP’s Hemostasis and Thrombosis Center Celebrates 50th Anniversary
A look back at the last five decades of treatment options to what lies ahead with additional potentially curative gene therapies.
CHOP Expert Breaks Down Latest Hemophilia A Gene Therapy Data
CHOP gene therapy expert Dr. Lindsey George reacts to a phase 3 hemophilia gene therapy study in an editorial in the New England Journal of Medicine.
NoT Bleeding Program Has Strong Presence at Premier Hematology Conference
CHOP experts in bleeding disorders care and research presented at the American Society of Hematology 2022 conference.